CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Treatments for stage B liver cancer
The following are treatment options for stage B liver cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.
Transarterial chemoembolization (TACE)
TACE is a treatment that blocks the blood supply to a liver tumour and delivers chemotherapy directly to the tumour. It is the standard treatment for people who have good liver function, have a good performance status and do not have increased pressure in the portal vein (called portal hypertension).
Targeted therapy uses drugs to target specific molecules (such as proteins) on the surface of cancer cells. These molecules help send signals that tell cells to grow or divide. By targeting these molecules, the drugs stop the growth and spread of cancer cells while limiting harm to normal cells. The targeted therapy drug used for stage B liver cancer is sorafenib (Nexavar).
Targeted therapy may be offered if you cannot have TACE because you have poor liver function or portal hypertension, or if TACE did not work.
You may be asked if you want to join a clinical trial for liver cancer. Find out more about clinical trials.
Taking action against all cancers
The latest Canadian Cancer Statistics report found that of all newly diagnosed cancers in 2017, half are expected to be lung, colorectal, breast and prostate cancers. Learn what you can do to reduce the burden of cancer.